About Alchemia

Alchemia is a biopharmaceutical company with a balanced portfolio of assets; 1) an established revenue stream from Fondaparinux sodium sold by Dr Reddy's, 2) a late stage oncology pipeline including HA-Irinotecan nearing completion of phase III in mCRC, and 3) a drug discovery platform used to access 3D chemical diversity.

Read More